Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Prediction of severe adverse drug reactions using pharmacogenetic biomarkers Tohkin M; Ishiguro A; Kaniwa N; Saito Y; Kurose K; Hasegawa RDrug Metab Pharmacokinet 2010[]; 25 (2): 122-33Severe adverse drug reactions (ADRs) are a major issue for drug therapy because they can cause serious disorders and be life-threatening. Many severe ADRs appear to be idiosyncratic and unpredictable. Genetic factors may underlie susceptibility to severe ADRs, and identification of predisposing genotypes may improve drug therapy by facilitating prescreening of carriers for specific genetic biomarkers. In this review, we clarify the current status of ADRs in Japan from open ADR data sources. Then, we introduce recent progress in the field of pharmacogenetic biomarkers for severe cutaneous ADRs, liver injury, and statin-induced myopathy. Key challenges for discovery of predictable risk alleles for these severe ADRs are also discussed.|*Drug-Related Side Effects and Adverse Reactions/*diagnosis[MESH]|Biomarkers/*analysis[MESH]|Chemical and Drug Induced Liver Injury[MESH]|Drug Monitoring[MESH]|Fusion Regulatory Protein-1/adverse effects[MESH]|Genetic Markers/*genetics[MESH]|Humans[MESH]|Japan[MESH]|Muscular Diseases/chemically induced[MESH]|Pharmacogenetics/*methods[MESH]|Stevens-Johnson Syndrome/chemically induced/etiology[MESH] |
